STOCK TITAN

Tempus AI SEC Filings

TEM NASDAQ

Welcome to our dedicated page for Tempus AI SEC filings (Ticker: TEM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Tempus AI, Inc. (NASDAQ: TEM) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Tempus is a healthcare technology company that applies artificial intelligence and multimodal data to precision medicine, and its filings offer insight into how it reports financial performance, manages capital, and documents material corporate events.

Investors can review Form 8-K filings where Tempus discloses items such as preliminary financial results, earnings press releases, credit agreement amendments, securities offerings, and other significant developments. For example, Tempus has used 8-K reports to furnish quarterly financial information, describe an automatic shelf registration statement and related prospectus supplement, and detail the terms of its convertible senior notes due 2030, including conversion features, redemption provisions, and associated capped call transactions.

Over time, this page will also surface Tempus’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for its Diagnostics and Data and applications businesses, risk factor discussions, and management’s analysis of operations. In addition, users can expect access to ownership and insider transaction disclosures, such as Form 4 filings, when they are available from EDGAR.

Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings in clear language. Real-time updates from EDGAR help ensure that new TEM filings appear promptly, while AI-generated highlights can draw attention to important terms in credit agreements, securities offerings, or covenant changes. This combination allows readers to navigate Tempus’s regulatory history more efficiently, from capital structure details to ongoing financial reporting.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Eric P. Lefkofsky, CEO, Chairman, and 10% owner of Tempus AI, executed significant stock sales through controlled entities on June 17-18, 2025, under a pre-established Rule 10b5-1 trading plan.

Key transaction details:

  • Through Gray Media LLC: Sold 50,000 shares at prices ranging $67.31-$71.21, reducing holdings to 9,307,283 shares
  • Through Blue Media LLC: Disposed of 400,000 shares at prices ranging $67.22-$71.16, reducing holdings to 15,427,132 shares

Post-transaction beneficial ownership includes 4,878,837 shares held directly, and indirect holdings through various entities including 10,000,000 shares in Lefkofsky Family 2025 GRAT. All transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2024, demonstrating planned, compliant insider selling activity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Erik Phelps, EVP & Chief Admin & Legal Officer of Tempus AI, executed significant stock sales on June 16, 2025, through a pre-planned Rule 10b5-1 trading arrangement established on September 6, 2024.

The transactions involved a total disposition of 51,317 shares of Class A Common Stock in multiple trades:

  • 29,333 shares at average price of $72.01
  • 11,186 shares at average price of $72.74
  • 8,898 shares at average price of $73.76
  • 1,900 shares at average price of $74.41

Following these transactions, Phelps retains direct beneficial ownership of 97,779 shares. The sales were executed at progressively higher price points ranging from $71.28 to $74.55, suggesting favorable market conditions during the trading window.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 Filing Details - Insider Trading Activity at Tempus AI

On June 16, 2025, Andrew Polovin, EVP and General Counsel of Tempus AI, executed a sale of 1,423 shares of Class A Common Stock at $72.13 per share. The transaction was conducted under a Rule 10b5-1 trading plan established on September 6, 2024.

Following the transaction, Polovin retains direct beneficial ownership of 137,454 shares of Class A Common Stock. Key transaction details:

  • Transaction Type: Sale (S)
  • Total Value: Approximately $102,641
  • Trading Plan: Executed under pre-established 10b5-1 plan
  • Ownership: Direct

This insider sale represents a relatively small portion (approximately 1%) of Polovin's total holdings in the company, suggesting routine portfolio management rather than a significant shift in position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Tempus AI (TEM)?

The current stock price of Tempus AI (TEM) is $51.4 as of March 3, 2026.

What is the market cap of Tempus AI (TEM)?

The market cap of Tempus AI (TEM) is approximately 9.5B.

TEM Rankings

TEM Stock Data

9.53B
104.78M
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States
CHICAGO

TEM RSS Feed